Pilot study of salivary butyrylcholinesterase, phosphodiesterase, thiols and cerulopalsmin in auditory neuropathy
- 31 December 2012
- journal article
- Published by Elsevier in Asian Pacific Journal of Tropical Disease
- Vol. 2, S471-S474
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Myelin 2′,3′-Cyclic Nucleotide 3′-Phosphodiesterase: Active-Site Ligand Binding and Molecular ConformationPLOS ONE, 2012
- Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic miceNeuroscience, 2011
- Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's diseaseBritish Journal of Pharmacology, 2011
- Emblica officinalis Corrects Functional, Biochemical and Molecular Deficits in Experimental Diabetic Neuropathy by Targeting the Oxido‐nitrosative Stress Mediated Inflammatory CascadePhytotherapy Research, 2011
- Concurrent targeting of nitrosative stress–PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathyBiochemical and Biophysical Research Communications, 2010
- Neuropathy‐induced apoptosis: Protective effect of physostigmineJournal of Neuroscience Research, 2009
- Copper deficiency myelopathy and subacute combined degeneration of the cord – Why is the phenotype so similar?Medical Hypotheses, 2008
- Pilot study of pyridostigmine in constipated patients with autonomic neuropathyClinical Autonomic Research, 2008
- Subacute combined degeneration due to copper deficiency.Journal of Neuroimaging, 2008
- Frequency-Specific Electrocochleography Indicates that Presynaptic and Postsynaptic Mechanisms of Auditory Neuropathy ExistEar & Hearing, 2008